The price that ends: first-month NAD+ prices, and what replaces them
376 figures from 106 sellers, read September 2026. Written September 2026.
Some of the lowest NAD+ figures published anywhere are charged exactly once. They are not discounts off an ongoing price so much as a different price with a shorter life, and the interesting question is not how low they go but whether the seller says what happens next.
A first-month price is a price with an expiry
A first-month price is not a discount in the ordinary sense. It is a different price with a shorter life: charged once, at the start, and replaced by something else afterwards. Sellers write it in a dozen ways — “first month”, “/first mo.”, “(For the first month)”, “First order discount” — and this index stores each wording exactly as printed, because the wording is the only thing that distinguishes it from a standing rate.
It matters more here than it would in most markets. NAD+ is sold on subscription, so the number a buyer commits to is almost never the number they first pay, and the gap between the two is sometimes large.
How many, and how many sellers
27 of the 376 figures read for this index are first-period prices, published by 11 of the 106 sellers. Separately, 15 figures carry a billing period that is itself only a first period — a seller saying, in the field where a cycle should go, that this applies once.
Both counts are small next to the 376, and the sellers who use the device are not the fringe of the roster. Several of the ones below run the whole of their published pricing on it.
The sellers who print what comes next
The best case for a reader is a seller who prints both numbers in one sentence. There is nothing to work out, nothing to match up, and nothing this site has to infer.
| Seller | The sentence, as printed |
|---|---|
| HealthOn | “Monthly Plan Billed and shipped monthly. $173 first month $196/mo after” |
| HealthOn | “3-Month Plan Billed every 3 months. Shipped monthly. $119 first month $186/mo after” |
| Brightmeds | “From $105 first month | then $155/mo*” |
| NativeMed | “Sale price $159.00 first month then $186/mo*” |
| TeleZen MD | “Compounded NAD+ Nose Spray 300 MG/15 ML Monthly Plan $98 first month $148/month after” |
| Sprout Health | “Monthly PLAN 1000mg (5mL vial) Enjoy flexibility + a first month discount $199 / first month $249 /mo after” |
| AgelessRx | “$79/first month Applies to 3-month plan billed in full ($149/mo after)” |
| Pallas Health | “Nasal spray: $79 for your first month, then $567 every 12 weeks ($189/mo average).” |
Pallas Health is the row to read twice. It is the only one here whose “after” figure is not a monthly charge: $567 every twelve weeks is the amount billed, and the $189 beside it is the seller’s own average of it. An average is a division, not a charge, so this index records the $567 as the price and the $189 as unresolved.
Source: Every cell is the seller’s own sentence around the figure, transcribed at reading time. Both numbers in each row come from the same quoted sentence — neither is paired by inference. Read September 2026.
Two of those rows repay a second look. Brightmeds moves from $105 to $155 a month, which is roughly a half again. AgelessRx’s $79 is not a standalone month at all — its own sentence says it applies to a three-month plan billed in full, so the $79 is the first month of a commitment rather than a month you can buy on its own.
The sellers who print no ongoing price at all
Then there is the other case, and it is the one worth coming to this page for.
| Seller | Everything it publishes |
|---|---|
| System Labs | “$119 $69 /first mo.” and “$149 $89 /first mo.” — two struck-looking pairs. Only the lower figure in each carries a label, and the page states no price after the first month |
| RxSpan MD | “Nicotinamide Adenine Dinucleotide ( NAD+ ) Injection $249 (For the first month)”, and the same wording for a nasal spray at $249 and a tablet at $199. No second-month figure appears on any of them |
These are the sharpest rows in this index, and they have to be rendered as an absence rather than as a jump: a reader can find out what the first month costs and cannot find out what the second one costs. That is a fact about the page, not an inference about the company.
Source: Every figure these sellers publish in this index is listed. Each quotation is the sentence printed around the figure at reading time. Read September 2026.
Neither seller is doing anything unusual by the standards of this market. What they are not doing is telling a reader what the product costs. A first-month price with no stated second month is a figure that answers a question nobody asked in place of the one everyone does.
Why this index will not pair them up for you
The tempting move on a page like this is a table with two columns, intro and ongoing, for all 11 sellers. It can be computed: take each first-period figure and pair it with the lowest standing rate the same seller publishes. It was computed, as a check, and it failed its own sanity test — in four of nineteen derived pairs the “ongoing” figure came out lower than the introductory one.
A result like that does not mean four sellers charge less later. It means the pairing was wrong: the seller publishes several products, or several plan lengths, and the cheapest standing rate belonged to a different one. Publishing the table anyway would have printed fifteen right answers and four confident wrong ones, all in the same typeface.
So the pairs on this page are only the ones the sellers made themselves. Every seller’s review page lists all of its figures with the kind and the wording attached, which is the honest way to see what a particular company charges after the first month: read what it printed.
What this page cannot tell you
It cannot tell you the ongoing price for every seller with an intro offer. For some of them that number is not published; for others it is published in a way that does not attach to the intro figure, and this index will not attach it for them.
It also cannot tell you what a first month includes that a later one does not, or the reverse. Whether a first payment covers a consultation, a lab test or a longer supply is not something this index has a field for, and the commitment behind a figure is a separate question with its own answer. All figures here were read on September 2026.
When a seller prints two figures side by side with nothing linking them, which one belongs to which? This index can record two figures and cannot record that they are a pair, or that they contradict each other.
A field naming the offer a figure is paired with, recorded at reading time. It is a schema shape rather than a value: no field can hold a disagreement between two other fields, which is why the figures that disagree are currently marked unresolved one by one instead of as the pairs they are.
Which named plan or tier does a figure belong to? A seller that publishes four figures usually names them — a monthly plan, a three-month plan, a starter tier — and this index records the figure, the cycle and the dose, but not the seller's own name for the package.
A reading pass that records the tier label verbatim beside each figure. Until then a reader comparing two figures from the same seller can see that they differ and not what the seller called each one.
About this page
Nobody at this site holds a medical license and nothing here is medical advice, diagnosis or treatment. This is a price index; the pages like this one exist because a reader cannot judge a price without knowing what the thing is. Talk to a licensed clinician before starting or stopping anything, and see the medical disclaimer.
Every count above is computed from this index’s own reading of 106 sellers’ pages, described below, and is recomputed each time this page is built — so it cannot drift from the tables and the reviews it is drawn from. If something here is wrong, the corrections page says how that gets fixed and what has been fixed before.
Where these figures come from
Every count on this page is computed, at the moment the page is built, from this index’s own record of what 106 NAD+ sellers publish about their prices: 376 figures in all, 344 of them distinct once 32 repeats of the same offer on a second surface are set aside, and 41 of them present only in a page’s markup rather than visible to a reader. Nothing here is typed into the prose, so a count in a sentence and the same count in a table cannot disagree.
All 376 figures were read on one day, September 2026, and there is no second reading. That is the standing limit on this page and on every page like it: nothing here says a price rose, fell or held, because nothing here has been measured twice. 7 of the 376 carry a flag saying they need reading again before they are relied on, and the reviews of the sellers concerned say which and why.
Each seller has a review page of its own listing every figure this index holds for it — the figure as the seller printed it, what kind of figure it is, the seller’s own words for the billing cycle, the day it was read and the address of the page it was read from. That is the trail from any number on this page back to a sentence a company published.